{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T06:28:10Z","timestamp":1768976890977,"version":"3.49.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","funder":[{"name":"UKRI Global Challenge Research Fund","award":["MR\/P027881\/1"],"award-info":[{"award-number":["MR\/P027881\/1"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To examine multimodal imaging findings in eyes before and after the onset of exudative macular neovascularization (ExMNV) bypassing the stage of pigmentation in Macular Telangiectasia Type-2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>From a total of 798 patients, Macular Telangiectasia Type-2 eyes with ExMNV that exhibited no signs of focal hyperpigmentation on color fundus photograph, fundus autofluorescence, and spectral-domain optical coherence tomography were retrospectively evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>There were 16 eyes of 16 patients (2%) with a mean age of 50.60 \u00b1 9.82 years. Among them, 11 eyes had ExMNV at the time of examination, whereas the remaining five eyes developed ExMNV during the follow-up period, all lacking pigment when it occurred. The average time for ExMNV development in the five eyes was 27.6 months (range: 11\u201346 months). Preceding signs of ExMNV included right-angled vessels and telangiectatic leaks causing the following optical coherence tomography changes\u2014temporal parafoveal thickening in three eyes, minimal intraretinal fluid pockets in three eyes, convex hyporeflective subretinal space in two eyes, and subretinal fluid in two eyes. With further declension\/descent of inner into outer retina, progression of ellipsoid zone loss was seen and outer retinal hyperreflectivity formed in areas with preexisting ellipsoid zone loss with visual acuity decline. Multiple retinal vessels formed an anastomosis with each other and extended into the center of the subretinal neovascular lesion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Patients with early Macular Telangiectasia Type-2 can proceed directly to ExMNV without pigmentation. Recognizing the signs before ExMNV develop will allow for closer follow-up and earlier treatment of these patients to prevent irreversible visual loss.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/iae.0000000000004716","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T02:03:26Z","timestamp":1762481006000},"page":"318-330","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["EXUDATIVE MACULAR NEOVASCULARIZATION BEFORE VISIBLE PIGMENTATION IN MACULAR TELANGIECTASIA TYPE-2 (MacTel)"],"prefix":"10.1097","volume":"46","author":[{"given":"Kiran","family":"Chandran","sequence":"first","affiliation":[{"name":"Department of Vitreoretinal Services, Giridhar Eye Institute, Cochin, Kerala, India;"},{"name":"SSM Eye Research Foundation, Giridhar Eye Institute, Cochin, Kerala, India; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7126-4885","authenticated-orcid":false,"given":"Anantharaman","family":"Giridhar","sequence":"additional","affiliation":[{"name":"Department of Vitreoretinal Services, Giridhar Eye Institute, Cochin, Kerala, India;"},{"name":"SSM Eye Research Foundation, Giridhar Eye Institute, Cochin, Kerala, India; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyoti Prakash","family":"Vyas","sequence":"additional","affiliation":[{"name":"Department of Vitreoretinal Services, Giridhar Eye Institute, Cochin, Kerala, India;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahesh","family":"Gopalakrishnan","sequence":"additional","affiliation":[{"name":"Department of Vitreoretinal Services, Giridhar Eye Institute, Cochin, Kerala, India;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sobha","family":"Sivaprasad","sequence":"additional","affiliation":[{"name":"NIHR Biomedical Research Centre, Moorfields Eye Hospital, NHS Foundation Trust, London, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260120","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.preteyeres.2012.11.002","article-title":"Macular telangiectasia type 2","volume":"34","author":"Charbel Issa","year":"2013","journal-title":"Prog Retin Eye Res"},{"key":"R2-20260120","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0161-6420(93)31447-8","article-title":"Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study","volume":"100","author":"Gass","year":"1993","journal-title":"Ophthalmology"},{"key":"R3-20260120","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1136\/bjophthalmol-2018-313364","article-title":"Right-angled vessels in macular telangiectasia type 2","volume":"105","author":"Tzaridis","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"R4-20260120","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1097\/IAE.0000000000002412","article-title":"New proposal for the pathophysiology of type 3 neovascularization as based on multimodal imaging findings","volume":"39","author":"Spaide","year":"2019","journal-title":"Retina"},{"key":"R5-20260120","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/IAE.0000000000000840","article-title":"Swept source optical coherence tomography angiography of neovascular macular telangiectasia type 2","volume":"35","author":"Zhang","year":"2015","journal-title":"Retina"},{"key":"R6-20260120","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/jamaophthalmol.2014.3950","article-title":"Retinal vascular layers in macular telangiectasia type 2 imaged by optical coherence tomographic angiography","volume":"133","author":"Spaide","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"R7-20260120","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1097\/IAE.0000000000000799","article-title":"Outer retina capillary invasion and ellipsoid zone loss in macular telangiectasia type 2 imaged by optical coherence tomography angiography","volume":"35","author":"Gaudric","year":"2015","journal-title":"Retina"},{"key":"R8-20260120","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1167\/iovs.15-18872","article-title":"Multimodal imaging of macular telangiectasia type 2: focus on vascular changes using optical coherence tomography angiography","volume":"57","author":"Toto","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R9-20260120","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1097\/IAE.0000000000001697","article-title":"Correlation of clinical and structural progression with visual acuity loss in macular telangiectasia type 2: Mactel project report no. 6-The MacTel Research Group","volume":"38","author":"Peto","year":"2018","journal-title":"Retina"},{"key":"R10-20260120","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.ophtha.2020.03.040","article-title":"Macular telangiectasia type 2: visual acuity, disease end stage, and the MacTel area MacTel project report number 8","volume":"127","author":"Heeren","year":"2020","journal-title":"Ophthalmology"},{"key":"R11-20260120","doi-asserted-by":"crossref","first-page":"100261","DOI":"10.1016\/j.xops.2022.100261","article-title":"Macular telangiectasia type 2: a classification system using MultiModal imaging MacTel project report number 10","volume":"3","author":"Chew","year":"2023","journal-title":"Ophthalmol Sci"},{"key":"R12-20260120","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1097\/IAE.0000000000001842","article-title":"Characteristics of pigmented lesions in type 2 idiopathic macular telangiectasia","volume":"38","author":"Leung","year":"2018","journal-title":"Retina"},{"key":"R13-20260120","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/archopht.124.4.450","article-title":"Idiopathic macular telangiectasia","volume":"124","author":"Yannuzzi","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"R14-20260120","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00417-006-0432-1","article-title":"Optical coherence tomography findings in idiopathic juxtafoveal retinal telangiectasis","volume":"245","author":"Surguch","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R15-20260120","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/IAE.0b013e3182695bb3","article-title":"Prevalence and progression of pigment clumping associated with idiopathic macular telangiectasia type 2","volume":"33","author":"Meleth","year":"2013","journal-title":"Retina"},{"key":"R16-20260120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10456-024-09954-4","article-title":"Retinal pigment epithelial cells reduce vascular leak and proliferation in retinal neovessels","volume":"28","author":"Tzaridis","year":"2024","journal-title":"Angiogenesis"},{"key":"R17-20260120","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1001\/archopht.120.3.320","article-title":"Neovascular membranes associated with idiopathic juxtafoveolar telangiectasis","volume":"120","author":"Engelbrecht","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"R18-20260120","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4103\/ojo.ojo_4_22","article-title":"Intraretinal and subretinal fluid in exudative nonproliferative macular telangiectasia type 2","volume":"15","author":"Manayath","year":"2022","journal-title":"Oman J Ophthalmol"},{"key":"R19-20260120","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1136\/bjophthalmol-2020-318470","article-title":"Morphological characteristics preceding exudative neovascularisation secondary to macular telangiectasia type 2","volume":"106","author":"Hess","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"R20-20260120","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1097\/IAE.0000000000004079","article-title":"From outer retinal neovascularization to exudative subretinal neovascularization in macular telangiectasia type-2","volume":"44","author":"Krivosic","year":"2024","journal-title":"Retina"},{"key":"R21-20260120","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.preteyeres.2017.07.002","article-title":"Optical coherence tomography angiography: a comprehensive review of current methods and clinical applications","volume":"60","author":"Kashani","year":"2017","journal-title":"Prog Retin Eye Res"},{"key":"R22-20260120","doi-asserted-by":"crossref","first-page":"e998","DOI":"10.1111\/aos.14110","article-title":"Progression characteristics of ellipsoid zone loss in macular telangiectasia type 2","volume":"97","author":"Pauleikhoff","year":"2019","journal-title":"Acta Ophthalmol"},{"key":"R23-20260120","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/IAE.0000000000002619","article-title":"Characterizing retinal-choroidal anastomosis in macular telangiectasia type 2 with optical coherence tomography angiography","volume":"40","author":"Breazzano","year":"2020","journal-title":"Retina"},{"key":"R24-20260120","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4274\/tjo.galenos.2025.19940","article-title":"Macular telangiectasia type 2: long-term disease progression and management of complications","volume":"55","author":"\u00d6zbek","year":"2025","journal-title":"Turk J Ophthalmol"},{"key":"R25-20260120","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/08820538.2021.1929347","article-title":"Long-term follow-up of visual acuity and incidence of subretinal neovascularization in Mactel type 2 in 82 eyes","volume":"37","author":"Marsonia","year":"2022","journal-title":"Semin Ophthalmol"},{"key":"R26-20260120","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/bjophthalmol-2020-317997","article-title":"Incidence and phenotypical variation of outer retina-associated hyperreflectivity in macular telangiectasia type 2","volume":"105","author":"Mueller","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"R27-20260120","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1136\/bjophthalmol-2015-307941","article-title":"Characteristics and quantification of vascular changes in macular telangiectasia type 2 on optical coherence tomography angiography","volume":"100","author":"Chidambara","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"R28-20260120","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1097\/IAE.0000000000002289","article-title":"Retinal-choroidal anastomosis in macular telangiectasia type 2","volume":"38","author":"Spaide","year":"2018","journal-title":"Retina"},{"key":"R29-20260120","doi-asserted-by":"crossref","first-page":"917","DOI":"10.5301\/ejo.5000363","article-title":"SD-OCT stages of progression of type 2 macular telangiectasia in a patient followed for 3 years","volume":"23","author":"Coscas","year":"2013","journal-title":"Eur J Ophthalmol"},{"key":"R30-20260120","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.ajo.2014.12.013","article-title":"Ciliary neurotrophic factor for macular telangiectasia type 2: results from a phase 1 safety trial","volume":"159","author":"Chew","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"R31-20260120","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1097\/IAE.0000000000001715","article-title":"Longitudinal correlation of ellipsoid zone loss and functional loss in macular telangiectasia type 2","volume":"38","author":"Heeren","year":"2018","journal-title":"Retina"},{"key":"R32-20260120","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ophtha.2018.09.041","article-title":"Effect of ciliary neurotrophic factor on retinal neurodegeneration in patients with macular telangiectasia type 2: a randomized clinical trial","volume":"126","author":"Chew","year":"2019","journal-title":"Ophthalmology"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004716","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T17:00:28Z","timestamp":1768928428000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004716","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]}}}